Very early researchWithdrawnNCT04891718What this trial is testingCIVO Intratumoural Microdosing of Anti-Cancer Therapies in AustraliaWho this might be right forSolid Tumour Presage Biosciences
Early research (Phase 1)Study completedNCT04456140What this trial is testingPro-Active Genetic Testing in Patients With Solid Tumors, Inherit StudyWho this might be right forBreast CarcinomaDigestive System NeoplasmMalignant Brain Neoplasm+8 more Mayo Clinic 230
Not applicableStudy completedNCT05581550What this trial is testingSomatostatin Receptor Imaging in NPC, EBV Related CancersWho this might be right forNasopharyngeal CancerEpstein-Barr Virus Related Carcinoma National Cancer Centre, Singapore 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03360890What this trial is testingPembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland TumorsWho this might be right forThyroid CancerSalivary Gland Cancer University of Chicago 46
Not applicableEnrolling By InvitationNCT06852144What this trial is testingPET-TC in Thyroid EvaluationWho this might be right forMedullary Thyroid CarcinomaHyperparathyroidismParathyroid Carcinoma IRCCS Azienda Ospedaliero-Universitaria di Bologna 418
Early research (Phase 1)Study completedNCT00030498What this trial is testingErlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more National Cancer Institute (NCI) 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT03224000What this trial is testingTrial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal CancerWho this might be right forMalignant Neoplasms of Lip Oral Cavity and PharynxOropharyngeal Cancer M.D. Anderson Cancer Center 90
Not applicableStudy completedNCT06666634What this trial is testingValidation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node BiopsyWho this might be right forPenile CancerMelanomaOral Cancer The Netherlands Cancer Institute 29
Early research (Phase 1)Study completedNCT00375245What this trial is testingRapamycin With Grapefruit Juice for Advanced MalignanciesWho this might be right forTumorsNeoplasm Metastasis University of Chicago 41
Early research (Phase 1)Not Yet RecruitingNCT07807345What this trial is testingPhase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or MetastaticWho this might be right forHead & Neck Squamous Cell CarcinomaNon-Small Cell Lung CancerEsophageal Cancer+5 more Sutro Biopharma, Inc. 285
Not applicableLooking for participantsNCT07124000What this trial is testingDESTINY-PANTUMOUR04Who this might be right forAdenocarcinoma (NOS)Anal CancerBladder Cancer+24 more AstraZeneca 100
Early research (Phase 1)Study completedNCT00054977What this trial is testingSafety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid TumorsWho this might be right forColorectal CancerLung CancerBreast Cancer+2 more Galectin Therapeutics Inc. 40
Early research (Phase 1)Study completedNCT01938612What this trial is testingA Phase I, Open-Label, Multicentre Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MEDI4736 in Patients With Advanced Solid TumoursWho this might be right forAdvanced Solid Tumors AstraZeneca 269
Testing effectiveness (Phase 2)Study completedNCT05012098What this trial is testingPhase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).Who this might be right forOlfactory NeuroblastomaEsthesioneuroblastomaNeoplasm of the Nasal Cavity National Cancer Institute (NCI) 11
Not applicableApproved For MarketingNCT03906331What this trial is testingExpanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) ActivationWho this might be right forNon Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+4 more Eli Lilly and Company
Early research (Phase 1)Ended earlyNCT05827614What this trial is testingStudy of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene AmplificationsWho this might be right forTriple Negative Breast Cancer (TNBC)High Grade Serous Ovarian CarcinomaHigh Grade Endometrial Carcinoma+9 more Boundless Bio, Inc. 85
Not applicableStudy completedNCT05851833What this trial is testingA Retrospective Study of Early Postoperative Mobilization in the Recovery of Patients With Oral Head and Neck Tumors Who Underwent Flap ReconstructionWho this might be right forLength of Hospital Stay Jie He, MD 244
Early research (Phase 1)Ended earlyNCT06580938What this trial is testingLearn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With CancerWho this might be right forNon Small Cell Lung CancerBladder CancerRenal Cell Carcinoma+3 more Pfizer 4
Early research (Phase 1)Ended earlyNCT04244552What this trial is testingA Phase 1b Trial of ATRC-101 in Adults With Advanced Solid MalignanciesWho this might be right forBreast CancerColorectal CancerOvarian Cancer+13 more Atreca, Inc. 87
Testing effectiveness (Phase 2)Study completedNCT00101348What this trial is testingErlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more National Cancer Institute (NCI) 66